Literature DB >> 20448094

D-dimer and exhaled CO2/O2 to detect segmental pulmonary embolism in moderate-risk patients.

Jeffrey A Kline1, Melanie M Hogg, D Mark Courtney, Chadwick D Miller, Alan E Jones, Howard A Smithline, Nicole Klekowski, Randy Lanier.   

Abstract

RATIONALE: Pulmonary embolism (PE) decreases the exhaled end-tidal ratio of carbon dioxide to oxygen (etCO(2)/O(2)).
OBJECTIVES: To test if the etCO(2)/O(2) can produce clinically important changes in the probability of segmental or larger PE on computerized tomography multidetector-row pulmonary angiography (MDCTPA) in a moderate-risk population with a positive D-dimer.
METHODS: Emergency department and hospitalized patients with one or more predefined symptoms or signs, one or more risk factors for PE, and 64-slice MDCTPA enrolled from four hospitals. D-dimer greater than 499 ng/ml was test(+), and D-dimer less than 500 ng/ml was test(-). The median etCO(2)/O(2) less than 0.28 from seven or more breaths was test(+) and etCO(2)/O(2) greater than 0.45 was test(-). MDCTPA images were read by two independent radiologists and the criterion standard was the interpretation of acute PE by either reader. PE size was then graded.
MEASUREMENTS AND MAIN RESULTS: We enrolled 495 patients, including 60 (12%) with segmental or larger, and 29 (6%) with subsegmental PE. A total of 367 (74%) patients were D-dimer(+), including all 60 with segmental or larger PE (posterior probability 16%). The combination of D-dimer(+) and etCO(2)/O(2)(+) increased the posterior probability of segmental or larger PE to 28% (95% confidence interval [CI] for difference of 12%, 3.0-22%). The combination of D-dimer(+) and etCO(2)/O(2)(-) was observed in 40 patients (8%; 95% CI, 6-11%), and none (0/40; 95% CI, 0-9%) had segmental or larger PE on MDCTPA. No strategy changed the prevalence of subsegmental PE.
CONCLUSIONS: In moderate-risk patients with a positive D-dimer, the et etCO(2)/O(2) less than 0.28 significantly increases the probability of segmental or larger PE and the etCO(2)/O(2) greater than 0.45 predicts the absence of segmental or larger PE on MDCTPA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20448094      PMCID: PMC2937237          DOI: 10.1164/rccm.201001-0129OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  26 in total

1.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

2.  The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; David Moher; Drummond Rennie; Henrica C W de Vet; Jeroen G Lijmer
Journal:  Clin Chem       Date:  2003-01       Impact factor: 8.327

3.  Prevalence and significance of nonthromboembolic findings on chest computed tomography angiography performed to rule out pulmonary embolism: a multicenter study of 1,025 emergency department patients.

Authors:  Peter B Richman; D Mark Courtney; Jeremy Friese; Jessica Matthews; Adam Field; Roland Petri; Jeffrey A Kline
Journal:  Acad Emerg Med       Date:  2004-06       Impact factor: 3.451

4.  Prospective multicenter assessment of interobserver agreement for radiologist interpretation of multidetector computerized tomographic angiography for pulmonary embolism.

Authors:  D M Courtney; C Miller; H Smithline; N Klekowski; M Hogg; J A Kline
Journal:  J Thromb Haemost       Date:  2009-12-14       Impact factor: 5.824

5.  Preliminary study of the capnogram waveform area to screen for pulmonary embolism.

Authors:  J A Kline; M Arunachlam
Journal:  Ann Emerg Med       Date:  1998-09       Impact factor: 5.721

6.  Clinicians' response to radiologists' reports of isolated subsegmental pulmonary embolism or inconclusive interpretation of pulmonary embolism using MDCT.

Authors:  Benjamin A Eyer; Lawrence R Goodman; Lacey Washington
Journal:  AJR Am J Roentgenol       Date:  2005-02       Impact factor: 3.959

7.  Diagnostic accuracy of a bedside D-dimer assay and alveolar dead-space measurement for rapid exclusion of pulmonary embolism: a multicenter study.

Authors:  J A Kline; E G Israel; E A Michelson; B J O'Neil; M C Plewa; D C Portelli
Journal:  JAMA       Date:  2001-02-14       Impact factor: 56.272

8.  Volumetric capnography as a screening test for pulmonary embolism in the emergency department.

Authors:  Franck Verschuren; Giuseppe Liistro; René Coffeng; Frédéric Thys; Jean Roeseler; Francis Zech; Marc Reynaert
Journal:  Chest       Date:  2004-03       Impact factor: 9.410

9.  Deadspace and the single breath test for carbon dioxide during anaesthesia and artificial ventilation. Effects of tidal volume and frequency of respiration.

Authors:  R Fletcher; B Jonson
Journal:  Br J Anaesth       Date:  1984-02       Impact factor: 9.166

10.  Severity of acute pulmonary embolism: evaluation of a new spiral CT angiographic score in correlation with echocardiographic data.

Authors:  Ioana Mastora; Martine Remy-Jardin; Pascal Masson; Eric Galland; Valérie Delannoy; Jean-Jacques Bauchart; Jacques Remy
Journal:  Eur Radiol       Date:  2002-06-19       Impact factor: 5.315

View more
  3 in total

Review 1.  Using the features of the time and volumetric capnogram for classification and prediction.

Authors:  Michael B Jaffe
Journal:  J Clin Monit Comput       Date:  2016-01-18       Impact factor: 2.502

2.  Derivation of a screening tool to identify patients with right ventricular dysfunction or tricuspid regurgitation after negative computerized tomographic pulmonary angiography of the chest.

Authors:  Jeffrey A Kline; Frances M Russell; Tim Lahm; Ronald A Mastouri
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

3.  PaCO2-EtCO2 Gradient and D-dimer in the Diagnosis of Suspected Pulmonary Embolism.

Authors:  Sayed Hamed Khajebashi; Maryam Mottaghi; Mohsen Forghani
Journal:  Adv Biomed Res       Date:  2021-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.